These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8426176)

  • 21. Effects of diversion on adults with co-occurring mental illness and substance use: outcomes from a national multi-site study.
    Broner N; Lattimore PK; Cowell AJ; Schlenger WE
    Behav Sci Law; 2004; 22(4):519-41. PubMed ID: 15282838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Service utilization and costs of care for severely mentally ill clients in an intensive case management program.
    Quinlivan R; Hough R; Crowell A; Beach C; Hofstetter R; Kenworthy K
    Psychiatr Serv; 1995 Apr; 46(4):365-71. PubMed ID: 7788458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central New York Psychiatric Center: an approach to the treatment of co-occurring disorders in the New York State correctional mental health system.
    Smith H; Sawyer DA; Way BB
    Behav Sci Law; 2002; 20(5):523-34. PubMed ID: 12239710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
    Havassy BE; Alvidrez J; Owen KK
    Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major mental disorders, substance use disorders, comorbidity, and HIV-AIDS risk behaviors in juvenile detainees.
    Teplin LA; Elkington KS; McClelland GM; Abram KM; Mericle AA; Washburn JJ
    Psychiatr Serv; 2005 Jul; 56(7):823-8. PubMed ID: 16020814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of community-based services by rural adolescents with mental health and substance use disorders.
    Anderson RL
    Psychiatr Serv; 2003 Oct; 54(10):1339-41. PubMed ID: 14557517
    [No Abstract]   [Full Text] [Related]  

  • 27. Scope of agency control: assertive community treatment teams' supervision of consumers.
    Moser LL; Bond GR
    Psychiatr Serv; 2009 Jul; 60(7):922-8. PubMed ID: 19564222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance use disorder comorbidity among inpatient youths with psychiatric disorder.
    Swadi H; Bobier C
    Aust N Z J Psychiatry; 2003 Jun; 37(3):294-8. PubMed ID: 12780467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients.
    Lehman AF; Myers CP; Thompson JW; Corty E
    J Nerv Ment Dis; 1993 Jun; 181(6):365-70. PubMed ID: 8388914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services.
    Weaver T; Madden P; Charles V; Stimson G; Renton A; Tyrer P; Barnes T; Bench C; Middleton H; Wright N; Paterson S; Shanahan W; Seivewright N; Ford C;
    Br J Psychiatry; 2003 Oct; 183():304-13. PubMed ID: 14519608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of supported employment in Latino consumers with severe mental illness.
    Mueser KT; Bond GR; Essock SM; Clark RE; Carpenter-Song E; Drake RE; Wolfe R
    Psychiatr Rehabil J; 2014 Jun; 37(2):113-22. PubMed ID: 24912060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental illness and substance misuse: a nursing challenge.
    Jackson-Koku G
    Br J Nurs; 2001 Feb 22-Mar 7; 10(4):242-6. PubMed ID: 12170649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions.
    Pasareanu AR; Vederhus JK; Opsal A; Kristensen Ø; Clausen T
    BMC Health Serv Res; 2017 Jan; 17(1):5. PubMed ID: 28049461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding clinical complexity in delinquent youth: comorbidities, service utilization, cost, and outcomes.
    Hussey DL; Drinkard AM; Falletta L; Flannery DJ
    J Psychoactive Drugs; 2008 Mar; 40(1):85-95. PubMed ID: 18472668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-occurring substance use and mental disorders among adults with opioid use disorder.
    Jones CM; McCance-Katz EF
    Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
    Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
    Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.